
Cefozopran hydrochloride
CAS No. 113981-44-5
Cefozopran hydrochloride( SCE-2787 hydrochloride )
Catalog No. M21205 CAS No. 113981-44-5
Cefozopran hydrochloride is a fourth-generation cephalosporin.?is a cell wall biosynthesis inhibitor with a broad spectrum of activity against Gram-positive and Gram-negative bacteria.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 182 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCefozopran hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefozopran hydrochloride is a fourth-generation cephalosporin.?is a cell wall biosynthesis inhibitor with a broad spectrum of activity against Gram-positive and Gram-negative bacteria.
-
DescriptionCefozopran hydrochloride is a fourth-generation cephalosporin.?is a cell wall biosynthesis inhibitor with a broad spectrum of activity against Gram-positive and Gram-negative bacteria.
-
In VitroCefozopran (SCE-2787) is a fourth-generation cephalosporin that has good activity against gram-positive organisms including methicillin-susceptible staphylococci, enterococci, and viridans group streptococci; and against gram-negative organisms including hemophilus influenza. Moreover, cefozopran has comparatively good activity against enterococci and P. aeruginosa, which are refractory to other cephalosporins.
-
In VivoCefozopran (SCE-2787) (5-80 mg/kg; s.c.; twice a day for 5 days; four-week-old ICR male mice) is effective against acute respiratory tract infections caused by Kiebsiella pneumonia DT-S. In the model of chronic respiratory tract infection caused by K. pneumoniae 27, Cefozopran (20-80 mg/kg; s.c.; twice a day for 7 days; five-week-old CBA/J female mice) is as effective as Ceftazidime.
-
SynonymsSCE-2787 hydrochloride
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number113981-44-5
-
Formula Weight551.99
-
Molecular FormulaC19H18ClN9O5S2
-
Purity>98% (HPLC)
-
SolubilityH2O:52 mg/mL (94.20 mM)
-
SMILESCO/N=C(\C1=NSC(=N1)N)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=C5C=CC=NN5C=C4)C(=O)[O-].Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wu G L Shentu J Z Zhou H L et al. Pharmacokinetics of Cefozopran by Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers[J]. Drugs in R & D 2015 15(1):63-70.
molnova catalog



related products
-
DSM 74
A potent, orally active PfDHODH inhibitor (IC50=0.3 uM) with antimalarial activity.
-
ETX2514
ETX2514 (ETX 2514, ETX-2514)?is a covalent, broad-spectrum β-lactamase inhibitor with IC50 of 4, 14 and 190 nM for class A KPC-2, class C AmpC and class D OXA-24, respectively.
-
Xyloidone
Xyloidone exhibits antifungal activity and completely inhibits the mycelial growth of B. cinerea, Colletotrichum acutatum Simmonds, Colletotrichum gloeosporioides Simmonds, M. grisea, and Pythium ultimum Trow over a range of 0.4-33.3 mg/L.